Want to join the conversation?
$UHS 2Q15 Call: Recorded net income attributable to UHS per diluted share of $1.80. Adjusted net income attributable to UHS increased approx. 20% to $186.6MM or $1.85 per diluted share vs. $155.6MM or $1.55 per diluted share during 2Q14. On a same facility basis in Acute division, revenues increased 8.4% over 2Q14.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.